BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 9789593)

  • 1. [Epidemiologic characteristics of 336 thyroid cancers observed in the Auvergne region].
    Bey-Boeglin M; Dejax C; Thiéblot P; Jourde H
    Ann Endocrinol (Paris); 1998 Jul; 59(2):99-105. PubMed ID: 9789593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
    Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occult thyroid carcinoma in our experience -- should we reconsider total thyroidectomy for benign thyroid pathology?
    Alecu L; Bărbulescu M; Ursuţ B; Enciu O; Slavu I; Braga V
    Chirurgia (Bucur); 2014; 109(2):191-7. PubMed ID: 24742409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy concept in differentiated thyroid gland carcinoma--results of 25 years with 257 patients].
    Gemsenjäger E; Heitz PU; Martina B; Schweizer I
    Praxis (Bern 1994); 2000 Nov; 89(44):1779-97. PubMed ID: 11109916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Papillary thyroid microcarcinoma in Denmark 1996-2008: a national study of epidemiology and clinical significance.
    Londero SC; Krogdahl A; Bastholt L; Overgaard J; Trolle W; Pedersen HB; Bentzen J; Schytte S; Christiansen P; Godballe C;
    Thyroid; 2013 Sep; 23(9):1159-64. PubMed ID: 23427917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cancers of the thyroid. Value of a regional registry on 627 patients diagnosed, treated and followed by a multidisciplinary team].
    Delisle MJ; Schvartz C; Theobald S; Maes B; Vaudrey C; Pochart JM
    Ann Endocrinol (Paris); 1996; 57(1):41-9. PubMed ID: 8734288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiated thyroid cancer in a Swedish county--long-term results and quality of life.
    Malterling RR; Andersson RE; Falkmer S; Falkmer U; Niléhn E; Järhult J
    Acta Oncol; 2010 May; 49(4):454-9. PubMed ID: 20092427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic importance of sclerosing variant in papillary thyroid carcinoma.
    Falvo L; Giacomelli L; D'Andrea V; Marzullo A; Guerriero G; de Antoni E
    Am Surg; 2006 May; 72(5):438-44. PubMed ID: 16719201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of residual occult malignancy in thyroid carcinoma.
    Turanli S; Aslan S; Cetin A
    Am J Otolaryngol; 2011; 32(5):398-401. PubMed ID: 21041002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer recurrence in papillary thyroid microcarcinoma: a multivariate analysis on 231 patients with a 12-year follow-up.
    Pedrazzini L; Baroli A; Marzoli L; Guglielmi R; Papini E
    Minerva Endocrinol; 2013 Sep; 38(3):269-79. PubMed ID: 24126547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management and outcome of recurrent well-differentiated thyroid carcinoma.
    Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical treatment of papillary and follicular thyroid carcinoma.
    Lin JD; Jeng LB; Chao TC; Weng HF; Huang HS
    Int Surg; 1996; 81(1):61-6. PubMed ID: 8803709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience.
    Lupone G; Antonino A; Rosato A; Zenone P; Iervolino EM; Grillo M; De Palma M
    G Chir; 2012; 33(11-12):395-9. PubMed ID: 23140924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifocality of thyroid carcinomas: a "privilege" of papillary tumors or not?
    Papageorgiou MS; Liratzopoulos N; Efremidou EI; Karanikas M; Minipoulos G; Manolas KJ
    G Chir; 2010; 31(1-2):20-3. PubMed ID: 20298661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifactorial analysis of survival and recurrences in differentiated thyroid cancer. Comparative evaluation of usefulness of AGES, MACIS, and risk group scores in Mexican population.
    Rodríguez-Cuevas S; Labastida-Almendaro S; Cortés-Arroyo H; López-Garza J; Barroso-Bravo S
    J Exp Clin Cancer Res; 2002 Mar; 21(1):79-86. PubMed ID: 12071534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
    Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
    Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Multifocal papillary thyroid carcinoma: clinical analysis of 168 cases].
    Lin YK; Sheng JM; Zhao WH; Wang WB; Yu XF; Teng LS; Ma ZM
    Zhonghua Wai Ke Za Zhi; 2009 Mar; 47(6):450-3. PubMed ID: 19595234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One in four patients with follicular thyroid cytology (THY3) has a thyroid carcinoma.
    Mihai R; Parker AJ; Roskell D; Sadler GP
    Thyroid; 2009 Jan; 19(1):33-7. PubMed ID: 18976164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Robotic total thyroidectomy with modified radical neck dissection via unilateral retroauricular approach.
    Byeon HK; Holsinger FC; Tufano RP; Chung HJ; Kim WS; Koh YW; Choi EC
    Ann Surg Oncol; 2014 Nov; 21(12):3872-5. PubMed ID: 25227305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic factors of papillary carcinomas of the thyroid gland--retrospective multivariate analysis of 227 patients with median follow-up 130 months].
    Kure Y
    Nihon Geka Gakkai Zasshi; 1992 Nov; 93(11):1420-6. PubMed ID: 1448049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.